Aura Biosciences, Inc. (AURA): Price and Financial Metrics
AURA Price/Volume Stats
| Current price | $6.07 | 52-week high | $12.38 |
| Prev. close | $5.83 | 52-week low | $4.84 |
| Day low | $5.62 | Volume | 163,700 |
| Day high | $6.09 | Avg. volume | 231,477 |
| 50-day MA | $6.47 | Dividend yield | N/A |
| 200-day MA | $8.25 | Market Cap | 304.87M |
AURA Stock Price Chart Interactive Chart >
Aura Biosciences, Inc. (AURA) Company Bio
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform to treat tumors of high unmet need in ocular and urologic oncology. Its AU-011, a VDC candidate, is being developed for the first line treatment of primary choroidal melanoma, a rare disease with no drugs approved. The company also develops AU-011 in additional ocular oncology indications, including choroidal metastases. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
AURA Price Returns
| 1-mo | 2.19% |
| 3-mo | -22.68% |
| 6-mo | -40.20% |
| 1-year | -21.88% |
| 3-year | -65.76% |
| 5-year | N/A |
| YTD | -26.16% |
| 2024 | -7.22% |
| 2023 | -15.62% |
| 2022 | -38.16% |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...